Deep Tech Startups

BioLM provides AI/ML solutions for protein and DNA analysis, serving researchers and scientists in the biotechnology and synthetic biology sectors with tailored models and APIs.

1 investor

Biologic Input Output Systems develops neural interface technology to restore natural movement and sensation for individuals with limb loss, enabling intuitive control of prosthetic limbs through direct brain-machine connections.

1 investor

Biologos is a GMP-certified manufacturer of custom cell culture media, buffers, and reagents for biopharmaceutical and research customers. The company specializes in rapid formulation and aseptic manufacturing of biologics-related products to support disease treatment and prevention efforts.

1 investor

Biomerics is a vertically integrated contract manufacturer for interventional medical devices, offering engineering, materials, and process expertise through 12 facilities. The company serves original equipment manufacturers in the medical device market with comprehensive design-to-manufacturing capabilities.

1 investor

Biomimetic manufactures specialty glass products with anti-reflective, anti-glare, and anti-fogging properties using green laser texturing technology. The company serves customers in optics, displays, and industrial applications requiring high light transmittance and durability.

1 investor

BioModAI provides an autonomous AI agent that designs molecular biology assays, primers, CRISPR guides, and DNA constructs for research and biotech teams. The agent runs real bioinformatics tools on actual genomic data and delivers publication-ready reports with full audit trails, typically within hours.

1 investor

Bionure Investment is a company based in Barcelona focused on developing solutions for neurodegenerative diseases affecting patients worldwide. The organization operates in the biotech and digital health sectors.

1 investor

BioPhenoMA develops a protein detection technology platform based on its proprietary TN-cyclon (improved enzyme cycling method) to quantify ultra-trace amounts of proteins in real biological samples while preserving their structure and localization. It targets biomedical and life-science researchers analyzing the mechanisms of biological phenomena.

1 investor

Bioptamers develops personalized precision cancer therapies that identify targetable molecular signatures unique to each patient's tumor and deliver therapeutics directly to cancer cells. Its target-agnostic platform aims to treat primary tumors and metastatic disease while reducing off-target effects.

1 investor

Bondwell Technologies develops protein-based materials for bioprocessing and biomanufacturing applications. The company's technology, discovered by academic researchers, is being scaled for commercial use in pharmaceutical, medical device, and regenerative medicine sectors.

1 investor

Bioretec develops fully biodegradable orthopedic implants for fracture healing and orthopedic surgery, including the RemeOs product line based on magnesium alloy and the Activa line of bioabsorbable implants. The company serves orthopedic surgeons and patients globally across approximately 40 countries.

1 investor

Waddle Labs is an applied AI research lab developing large language models that control robots, with a focus on letting individuals adapt robots to their own tasks and environments. Its research spans continual learning for transferring agent knowledge, real-time inference efficiency on physical robots, and human-robot interaction interfaces.

1 investor

Bios Partners is a venture capital firm focused on life sciences and biotech investments, providing diligence and portfolio support for clinical-stage and precision medicine companies. The firm combines deep expertise in drug development, pharmaceutical R&D, and equity research for healthcare institutions.

1 investor

BioSeek builds an AI platform for drug discovery that unifies fragmented biological sources—literature, patents, clinical, and chemistry data—into a connected knowledge graph, with specialist agents that reason across it from disease biology to safety-screened molecules. The software is deployed inside a customer's own infrastructure so proprietary data and tools join the private graph without leaving their environment, targeting enterprise pharma and biotech research teams.

1 investor

Biosens8 develops wearable health monitoring devices that track physiological markers including cortisol and women's health metrics. The company serves health-conscious consumers interested in personal biometric monitoring.

1 investor

BioSensTech sells electrochemical equipment and accessories, including potentiostat analyzers and specialized components, through an online store. It serves laboratories and professionals working in electrochemistry and also offers technical support and advisory services.

1 investor

Biosortia develops an aquatic natural products drug discovery platform, leveraging marine organisms to identify pharmaceutical compounds for various therapeutic areas.

1 investor

Biotitan develops nanotechnology-based surface treatments with bactericidal and virucidal properties for various environments. The company offers tailored turnkey solutions, training, and custom application services.

1 investor

Biotree develops metabolomics and proteomics analysis platforms and services for research institutions and pharmaceutical companies, offering laboratory testing solutions, medical devices, and cloud-based lab information systems.

1 investor

BIRD Aerosystems develops special mission aircraft solutions and airborne defense systems including missile protection, electronic warfare capabilities, and sensor technologies for military and government applications worldwide.

1 investor

Ginkgo provides autonomous laboratory systems that automate manual benchwork in biotechnology research, enabling scientists to focus on experimental design and insight rather than routine lab tasks.

1 investor

BITSILICA is a semiconductor and embedded systems engineering services firm providing IP/SoC verification, ASIC/RTL and physical design, FPGA design, and embedded work such as device drivers, automotive, and IoT. It serves over 25 global clients across India, the USA, Singapore, Malaysia, and Vietnam, and was acquired by Quest Global.

1 investor

BitVMX is an open research project building a production-ready implementation of the BitVMX platform and a BitVMX RISC-V processor capable of running RISC-V programs on Bitcoin. It aims to pass the official RISC-V test suite and is developed by contributors from Rootstock Labs and Fairgate Labs.

1 investor

bitvox is a deep-tech company working at the intersection of hardware, software, and artificial intelligence, developing and operating connected physical systems from circuit board to cloud platform. It builds in-house AI models for acoustic and speech processing and covers the full stack—hardware, embedded software, and cloud infrastructure—within one team.

1 investor